What is Wall Street's Target Price for Petco Health and Wellness Company Inc (WOOF) Stock Friday? – InvestorsObserver

Share Article

InvestorsObserver is giving Petco Health and Wellness Company Inc (WOOF) an Analyst Rating Rank of 17, meaning WOOF is ranked higher by analysts than 17% of stocks. The average price target for WOOF is $24.833 and analyst’s rate the stock as a Buy.

Overall Score - 3.5
Wall Street analysts are rating WOOF a Buy today. Find out what this means to you and get the rest of the rankings on WOOF!

Why are Analyst Ratings Important?

Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers. InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.

What’s Happening With Petco Health and Wellness Company Inc Stock Today?

Petco Health and Wellness Company Inc (WOOF) stock is trading at $14.96 as of 11:31 AM on Friday, May 20, a loss of -$1.81, or -10.79% from the previous closing price of $16.77. The stock has traded between $14.72 and $16.75 so far today. Volume today is elevated. So far 4,566,097 shares have traded compared to average volume of 2,738,759 shares. Click Here to get the full Stock Report for Petco Health and Wellness Company Inc stock.
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You’re all set to receive the Morning Update newsletter
Stock Price data may be delayed up to 15 minutes.
Copyright © 2022. Portions of this content may be copyrighted by Fresh Brewed Media, Investors Observer, and/or O2 Media LLC. All Rights Reserved. Portions of this content protected by US Patent numbers 7,865,496, 7,856,390, and 7,716,116. Investing in stocks, bonds, option and other financial instruments involve risks and may not be suitable for everyone. Portfolio results are unaudited and based on varying investment expiration dates. Terms of Service | Privacy Policy


You might also like

Surviving 2nd wave of corona

Surviving The 2nd Wave of Corona

‘This too shall pass away’ this famous Persian adage seems to be defeating us again and again in the case of COVID-19. Despite every effort